ESGE AI Survey

Introduction

In recent years, Artificial Intelligence (AI) has entered the market to assist the endoscopist in detecting colorectal polyps and cancer in real time during colonoscopy. AI has been shown to increase detection rates of small adenomas and non-neoplastic polyps. However, although more than 40 randomized controlled trials have evaluated AI for colon polyp detection, it remains unclear whether the increased detection rate (12.7% vs 11.5%) of advanced colorectal neoplasia (polyps ≥10 mm, with high grade dysplasia, or with villous features), which have the most potential for malignant transition, represents a clinically meaningful difference.

Moreover, higher adenoma detection rates (ADR) with the use of AI during colonoscopy may translate to a clinically meaningful reduction of colorectal cancer (CRC) risk after colonoscopy. However, it also remains uncertain whether this potential benefit of AI outweighs the additional burden of higher detection rates of non-neoplastic polyps and the consequential unnecessary removal of such polyps.

To date, there is very limited data evaluating the attitudes and beliefs of endoscopists who perform screening and surveillance colonoscopy and the role of AI in those examinations. The ESGE is therefore conducting this online survey of ESGE members to obtain this important data. We believe this data will better inform the role and positioning of AI in screening / surveillance colonoscopy in the coming years.

ESGE thanks you for completing this anonymous survey.